Stockreport

Vaxart Issues Statement Regarding Proposed Merger With Aviragen

Atea Pharmaceuticals, Inc. - common stock  (AVIR) 
PDF SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Vaxart, Inc. today commented on the Company’s proposed merger with Aviragen Therapeutics, Inc. (NASDAQ:AVIR) [Read more]